Morgan Stanley Earnings Preview: Forward Estimate Revisions Steadily Positive
Morgan Stanley is scheduled to report 3rd quarter 2024 financial results on Wednesday morning, October 16th, before the ...
Financial stocks are still being woefully underappreciated by investors, Morgan Stanley says
Investors haven't yet readjusted their portfolios to reflect strong US macro data, creating an opportunity in financial ...
Morgan Stanley: Dividends And Deals You Can Bank On
Morgan Stanley has proven itself as a very resilient and innovative financial powerhouse. Find out why I upgrade MS stock ...
Jim Cramer Expresses Concern About Morgan Stanley (MS)’s Performance In China
We recently compiled a list of the Jim Cramer is Talking About These 14 Stocks Before Earnings. In this article, we are going ...
Europe’s population crisis could shave 4% off its GDP by 2040, Morgan Stanley warns, and ...
Europe’s demographic challenges are becoming a ticking time bomb for the region’s economy, with Morgan Stanley delivering a ...
Are investors overlooking financial stocks in favor of defensive trades? Morgan Stanley ...
Investors are currently focused on defensive trades, missing out on the strength of the economy, according to a report from ...
金融界财经 on MSN3 天
跟黄仁勋面谈后，Morgan Stanley更加坚定看涨NVDA
分析师Joseph Moore重申了对这家芯片制造商的“增持”评级，并表示与英伟达CEO及其他管理层的会晤进一步增强了摩根士丹利对其是半导体行业的首选股的观点。摩根士丹利本周为 英伟达 举办了为期三天的非交易路演。
Caterpillar downgraded by Morgan Stanley. Here's why.
Caterpillar (CAT) shares dip Monday morning after Morgan Stanley's analyst team downgraded the stock to Underweight and cut ...
金融界财经 on MSN5 天
摩根士丹利：因为税务，这些股票最有可能先开始下跌
Morgan Stanley表示，2024年一些跌幅最大的股票可能会因为投资者抛售以节省税收而面临更大幅度的下跌。10月对三大股指来说动荡不安——随着投资者应对中东局势紧张以及急剧上涨的油价，本月股指普遍下跌——但整个2024年，S&P ...
Business Insider11 天
Morgan Stanley
Investors haven't readjusted their portfolios to reflect strong US macro data, creating an opportunity in financial stocks, Morgan Stanley says. The US dollar won't be displaced by any of its ...
Morgan Stanley将Levi Strauss股票目标价下调至19美元
周四，Morgan Stanley调整了对Levi Strauss & Co.
Morgan Stanley设定Edwards Lifesciences股票目标价
周五，Morgan Stanley恢复了对医疗设备行业领先企业Edwards Lifesciences (NYSE: EW)股票的覆盖，给予"与大盘持平"评级，目标价为$70.00。该公司强调了Edwards Lifesciences强劲的财务状况和潜在的积极发展，但同时表示当前股价已经反映了预期增长。